DCA50, a novel inhibitor of the intracellular copper chaperone proteins ATOX1 and CCS, can induce an increase in cellular copper content and subcellular redistribution of copper by interfering with cellular copper homeostasis, thereby inhibiting tumor angiogenesis and inducing apoptosis in triple-negative breast cancer cells (104). The gene discussed is ATOX1; the disease is neoplasm.